April 29

2015

Q&A: Mayer Brown's Brian Nolan on strategy behind drug patent challenges

Reuters (subscription required)

Home
News
Q&A: Mayer Brown's Brian Nolan on strategy behind drug patent challenges

Related People

Brian W. Nolan

In this Q&A interview, Intellectual Property partner Brian Nolan (New York) discusses strategy behind drug patent challenges.

Related Capabilities

Practices –

Industries –

Life Sciences

News

July 02

2020

Mayer Brown advises MVP Capital on sale to Houlihan Lokey
June 30

2020

17 Mayer Brown lawyers named to The Legal 500’s “Hall of Fame”
June 12

2020

Mayer Brown partners Lisa Ferri and Gabriela Kennedy named to list of “Top 250 Women in IP 2020” by Managing Intellectual Property
June 09

2020

Mayer Brown launches Immuno-Innovation blog
Spring 2020

Determined Team Leader

Northwestern Engineering